Wednesday, 18 November 2026NewsWorldBusinessTech
Latest

Chinese Scientists’ Detangle Comb Achieves Nearly 100% Hair Regrowth in Mice

An experimental electric comb achieved nearly 100 per cent hair regrowth in mice during a 28-day study, according to researchers at Beihang University in China.

The device, named “Detangle,” uses microelectronics to deliver electrical pulses and therapeutic molecules deep into hair follicles to combat androgenetic alopecia (AGA), a form of pattern hair loss. The researchers published their findings in the journal Nature Communications on 3 November 2026. This research was a joint effort involving Beihang University and City University of Hong Kong, among others.

Scientists Unveil Electric Comb That Regrew Nearly 100% of Hair in Mice: Could Brits Ever Use One? — UK Innovation Report

The technology aims to address a primary challenge in treating pattern baldness: ensuring medication reaches the target cells. “Safe and efficient delivery remains the key to the treatment outcome of AGA,” the study authors wrote. Androgenetic alopecia affects more than 1.5 billion people worldwide and can affect up to 80 per cent of men during their lifetimes, often causing psychological and quality-of-life burdens.

Detangle system combines electrical stimulation with gene therapy

The Detangle system functions by combining electrical stimulation with two specific genetic treatments. The comb features teeth of different heights embedded with electrodes, which generate a directional electric field that penetrates approximately nine times deeper than conventional topical applications, according to the research paper.

Chinese Scientists' Detangle Comb Achieves Nearly 100% Hair Regrowth in Mice
Photo: The Brighter Side of News

This process uses electroporation to temporarily increase cell-membrane permeability, allowing molecules to enter hair follicle cells more effectively. At the achieved depth, the transmembrane potential induced by combing exceeded 0.7 volts.

The researchers utilized two distinct molecules to target different biological pathways:

  • A VEGFA plasmid designed to encourage the growth of new blood vessels around the follicles to improve blood supply.
  • An SRD5A2 siRNA intended to reduce the production of dihydrotestosterone (DHT), a hormone that shrinks hair follicles and leads to progressively thinner hair.

Comparison of hair regrowth rates

To model the condition, researchers shaved patches on the backs of male mice and administered testosterone for 28 days. Over a 28-day period, the combination of electrical stimulation and both therapeutic molecules reached a hair coverage rate of 97.85 per cent. This outperformed both the electrical stimulation alone and the individual molecules when paired with stimulation.

The following table compares the regrowth rates observed in the mouse model after one month of treatment:

Treatment Method Regrowth Rate (One Month)
Detangle (Full Combination) ~100%
VEGFA plasmid + stimulation ~90%
SRD5A2 siRNA + stimulation ~85%
Minoxidil (Topical drug) ~70%
Finasteride (Oral drug) ~50%
Electrical stimulation only ~40%
Untreated control ~1%

The researchers said that while topical minoxidil is a common treatment, it only achieved approximately 70 per cent regrowth in the test group, while the oral drug finasteride saw about 50 per cent, SCMP reported.

Biological improvements and safety

Beyond surface regrowth, the combination treatment showed improvements in local blood flow and hair follicle counts. Tissue analyses suggested the device successfully increased vascular-related indicators in the treated areas. Gizmodo reported that tests also confirmed the comb effectively delivered the molecules without causing noticeable harm to the skin of the mice.

The device’s name was inspired by the 2010 Disney animated film Tangled, SCMP noted. The researchers wrote that “the results demonstrate that electrical stimulation using the Detangle system can promote hair growth and follicle regeneration in a safe and effective manner,” and further stated the system “proved it is safe and effective for deep tissue delivery in the dermatology field.”

Person with thinning hair credit pu kibun
Photo: Engineering and Technology Magazine

Path toward human application

The Detangle system is currently a laboratory prototype and has not been tested in human volunteers. It is not known whether the device would be safe or effective for people. Experts emphasize that findings in mice do not necessarily translate to humans, as testosterone-induced hair loss in animals is not a direct equivalent to human androgenetic alopecia.

While the study provides a promising proof of concept, human trials would need to establish how well the device works, how safe it is, and whether any biological gains last. For anyone concerned about hair loss, it is important to consult with a qualified medical professional to discuss established and approved treatment options.

“The Detangle system presents a versatile platform for co-delivering therapeutic agents beyond metabolic modulation,” the researchers concluded in their study.